The market expansion and approvals update at least got some decent national coverage for those who did not see:
https://www.theaustralian.com.au/business/*/content/orthocell-ramps-up-global-expansion-of-marketleading-regenerative-medicine-products/news-story/cdb7ec3d821b19b780c2dcca7c8b4299
The business is improving (the much hearalded 30% revenue growth does indeed need to accelerate) and the foundations for expansion there, but the casual effects of media coverage in smaller capped stocks not to be underestimated. I think OCC featured once before in the Fin Review from memory:
https://www.copyright link/companies/healthcare-and-fitness/the-key-to-this-biotech-s-tilt-at-us-fortune-is-pure-pigs-20231030-p5eg4k
Another would be nice for share price progression....
The market expansion and approvals update at least got some...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.010(2.56%) |
Mkt cap ! $79.54M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.3¢ | 38.0¢ | $18.00K | 46.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13231 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 6904 | 2 |
View Market Depth
| Last trade - 15.21pm 25/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |